Global Cord Blood Corporation to Report Fourth Quarter and Full Year Fiscal 2021 Financial Results
Earnings Call Scheduled for 8:00 a.m. ET on June 29, 2021
Get Alerts CO Hot Sheet
Join SI Premium – FREE
HONG KONG, June 22, 2021 /PRNewswire/ -- Global Cord Blood Corporation (NYSE: CO) (the "Company"), China's leading provider of cord blood collection, laboratory testing, hematopoietic stem cell processing and stem cell storage services, today announced that it plans to release unaudited financial results for the fourth quarter and full year fiscal 2021 on Monday, June 28, 2021, after the U.S. market close.
The Company will host a conference call at 8:00 a.m. ET on Tuesday, June 29, 2021 to discuss its financial performance and give a brief overview of the Company's recent developments, followed by a question-and-answer session. Interested parties can access the audio webcast through the Company's IR website at http://ir.globalcordbloodcorp.com. A replay of the webcast will be accessible two hours after the conference call and available for seven days at the same URL as above. Listeners can also access the call by dialing 1-646-722-4977 or 1-855-824-5644, for U.S. callers, or +852-3027-6500, for Hong Kong callers, access code: 27000750#.
Please dial in ten minutes prior to the conference call to ensure proper connection, and be prepared to provide your name and company name to the operator.
Supplemental financial information referenced in the conference call and the fourth quarter fiscal 2021 earnings press release will be available at http://www.globalcordbloodcorp.com, in the section titled "Investor Center/Press Release," after 4:16 p.m. ET on Monday, June 28, 2021, and in the Company's Report on Form 6-K for the month of June 2021, available on the Securities and Exchange Commission's website at www.sec.gov.
About Global Cord Blood Corporation
Global Cord Blood Corporation is the first and largest umbilical cord blood banking operator in China in terms of geographical coverage and the only cord blood banking operator with multiple licenses. Global Cord Blood Corporation provides cord blood collection, laboratory testing, hematopoietic stem cell processing and stem cell storage services. For more information, please visit the Company's website at: http://www.globalcordbloodcorp.com.
For more information, please contact:
Global Cord Blood CorporationInvestor Relations DepartmentTel: (+852) 3605-8180Email: [email protected]
ICR, Inc.William ZimaTel: (+86) 10-6583-7511U.S. Tel: (+1) 646-405-5185Email: [email protected]
View original content:http://www.prnewswire.com/news-releases/global-cord-blood-corporation-to-report-fourth-quarter-and-full-year-fiscal-2021-financial-results-301316953.html
SOURCE Global Cord Blood Corporation
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Fisker (FSR) files form 10-K, sees more job cuts, reiterates going concern doubts
- 10X Capital Venture Acquisition Corp. III (VCXB) Receives NYSE Notice Regarding Late Form 10-K Filing
- Direct Digital Holdings (DRCT) Receives Nasdaq Non-compliance Notice
Create E-mail Alert Related Categories
PRNewswire, Press ReleasesRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!